We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

147 hedge funds and large institutions have $330M invested in Spectrum Pharmaceuticals Inc in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 44 increasing their positions, 53 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less capital invested

Capital invested by funds: $341M → $330M (-$11.5M)

9% less funds holding

Funds holding: 161147 (-14)

17% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 53

57% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 23

65% less call options, than puts

Call options by funds: $297K | Put options by funds: $851K

Holders
147
Holders Change
-14
Holders Change %
-8.7%
% of All Funds
2.58%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
10
Increased
44
Reduced
53
Closed
23
Calls
$297K
Puts
$851K
Net Calls
-$554K
Net Calls Change
-$112K
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$91.8M +$1.26M +352,449 +1%
State Street
2
State Street
Massachusetts
$42.8M +$9.11M +2,539,908 +24%
Vanguard Group
3
Vanguard Group
Pennsylvania
$41.2M +$1.89M +527,765 +4%
AC
4
Armistice Capital
New York
$34.9M +$3.97M +1,108,000 +12%
Macquarie Group
5
Macquarie Group
Australia
$12.9M +$3.78M +1,053,185 +36%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$7.83M +$776K +216,544 +10%
Dimensional Fund Advisors
7
Dimensional Fund Advisors
Texas
$6.53M +$1.3M +361,571 +22%
Renaissance Technologies
8
Renaissance Technologies
New York
$5.4M -$2.58M -720,662 -30%
Northern Trust
9
Northern Trust
Illinois
$5.33M -$230K -64,108 -4%
ACM
10
Alethea Capital Management
Washington
$5.21M +$213K +59,500 +4%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$4.74M -$220K -61,448 -4%
Two Sigma Advisers
12
Two Sigma Advisers
New York
$4.34M +$127K +35,500 +3%
Morgan Stanley
13
Morgan Stanley
New York
$3.98M +$1.07M +297,174 +32%
Principal Financial Group
14
Principal Financial Group
Iowa
$3.42M +$57.9K +16,155 +2%
Charles Schwab
15
Charles Schwab
California
$3.22M +$65.4K +18,249 +2%
Invesco
16
Invesco
Georgia
$2.68M -$186K -51,958 -6%
Citigroup
17
Citigroup
New York
$2.38M +$2.43M +677,577 +1,254%
PPA
18
Parametric Portfolio Associates
Washington
$2.28M -$220K -61,371 -8%
Wells Fargo
19
Wells Fargo
California
$2.27M +$157K +43,688 +7%
Ameriprise
20
Ameriprise
Minnesota
$2.08M +$106K +29,627 +5%
N
21
Nuveen
North Carolina
$2.06M -$41K -11,432 -2%
JP Morgan Chase
22
JP Morgan Chase
New York
$2.04M -$12.7K -3,537 -0.6%
Two Sigma Investments
23
Two Sigma Investments
New York
$2.01M -$3.4M -947,254 -61%
Bank of America
24
Bank of America
North Carolina
$1.99M +$930K +259,427 +74%
Rafferty Asset Management
25
Rafferty Asset Management
New York
$1.91M +$1.76M +491,733 +532%

SPPI Hedge Fund Activity: Q1 2021 in Review

147 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2021, worth a combined $330M — down 3.4% from $341M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of SPPI and 10 opened new positions — a net loss of 13 holders — while 53 trimmed existing stakes and 44 added.

The largest buyer was State Street, adding an estimated $9.11M. The largest seller was Boxer Capital, exiting entirely with an estimated $11.4M sold.

  • 147 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2021, down from 161 in Q4 2020.
  • Funds reported $330M of Spectrum Pharmaceuticals Inc stock for Q1 2021, down 3.4% quarter-over-quarter.
  • 10 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2021 and 23 closed out, a net change of -13 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q1 2021 was State Street, an estimated $9.11M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q1 2021 was Boxer Capital, an estimated $11.4M sold.

Based on aggregated 13F filings for Q1 2021.